Efficacy of Subgingival Application of Xanthan-based Chlorhexidine Gel Adjunctive to Full-mouth Root Planing Assessed by Real-time PCR: A Microbiologic and Clinical Study
Overview
Authors
Affiliations
Background And Aims: The aim of this clinical investigation was to compare clinical and microbiological effectiveness of adjunctive CHX gel in the treatment of periodontitis.
Materials And Methods: Twenty-four subjects with localized or generalized moderate-to-severe chronic periodontitis underwent scaling and root planing. One tooth in each quadrant with a probing depth of >4 mm was chosen for combined gel and SRP, with contralateral tooth as control (SRP treated site). Clinical assessment was carried out at baseline and 1 and 3 months later; microbial assessment was performed by real-time PCR. Periodontal probing depth (PPD) was considered as primary outcome.
Results: Twenty patients completed the study. Baseline PPDs were 4.90±0.78 and 5.05±0.79 in the SRP and gel groups, respectively (P>0.05), which decreased to 3.67±0.59 and 3.7±0.83 one month after treatment and 3.25±0.65 and 3.38±0.79 three months after treatment. Although values decreased significantly in both groups after one and three months (P=0.001 in the SRP and P=0.001 in the gel group), the inter-group difference was not significant neither at one-month (P=0.47) nor at three-month (P=0.77) intervals. The only clinical parameters exhibiting statistically significant inter-group differences was BOP in both one-month (P=0.004) and three-month (P=0.0001) intervals. All the other clinical measurements showed significant decreases after one and three months in both sites but without inter-group differences.
Conclusion: Subgingival application of xanthan chlorhexidine gel combined with scaling and root planing reduced bleed-ing of periodontal pockets. Clinical trials to evaluate effectiveness of this gel in aggressive and severe periodontitis modified by systemic factors are suggested.
Gels as adjuvant to non-surgical periodontal therapy: A systematic review and meta-analysis.
Gegout P, Stutz C, Huck O Heliyon. 2023; 9(7):e17789.
PMID: 37455970 PMC: 10345361. DOI: 10.1016/j.heliyon.2023.e17789.
Dalvi S, Benedicenti S, Salagean T, Bordea I, Hanna R Pharmaceutics. 2021; 13(6).
PMID: 34200078 PMC: 8228221. DOI: 10.3390/pharmaceutics13060836.
Butera A, Maiorani C, Natoli V, Bruni A, Coscione C, Magliano G J Clin Med. 2020; 9(12).
PMID: 33276626 PMC: 7761598. DOI: 10.3390/jcm9123914.
Zhao H, Hu J, Zhao L BMC Oral Health. 2020; 20(1):34.
PMID: 32005169 PMC: 6995104. DOI: 10.1186/s12903-020-1021-0.
In vitro chlorhexidine release from alginate based microbeads for periodontal therapy.
Scholz M, Reske T, Bohmer F, Hornung A, Grabow N, Lang H PLoS One. 2017; 12(10):e0185562.
PMID: 28973028 PMC: 5626444. DOI: 10.1371/journal.pone.0185562.